Mini Review
Published on 21 Jun 2021
Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.684162
- 34,578 views
- 76 citations
Type at least 3 characters
656 articles
articles
Brief Research Report
Published on 16 Jun 2021
ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.698966
- 4,246 views
- 6 citations
Correction
Published on 10 Jun 2021
Corrigendum: Cinical, Metabolic, and Genetic Analysis and Follow-Up of Eight Patients With HIBCH Mutations Presenting With Leigh/Leigh-Like Syndrome
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.686933
- 1,920 views
Original Research
Published on 09 Jun 2021
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.688386
- 9,107 views
- 19 citations
Review
Published on 09 Jun 2021
From Genome to Drugs: New Approaches in Antimicrobial Discovery
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.647060
- 15,509 views
- 48 citations
Original Research
Published on 07 Jun 2021
Comparative Analysis for the Performance of Long-Read-Based Structural Variation Detection Pipelines in Tandem Repeat Regions
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.658072
- 3,911 views
- 4 citations
Original Research
Published on 03 Jun 2021
Theragnosis for Duchenne Muscular Dystrophy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.648390
- 7,095 views
- 7 citations
Case Report
Published on 28 May 2021
Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.648519
- 5,614 views
- 8 citations
Original Research
Published on 26 May 2021
HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.671572
- 7,215 views
- 12 citations
Original Research
Published on 21 May 2021
Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.688950
- 11,330 views
- 22 citations
Original Research
Published on 21 May 2021
MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.674252
- 3,451 views
- 8 citations
Original Research
Published on 19 May 2021
Pharmacogenetic Associations Between Atazanavir/UGT1A1*28 and Efavirenz/rs3745274 (CYP2B6) Account for Specific Adverse Reactions in Chilean Patients Undergoing Antiretroviral Therapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.660965
- 5,951 views
- 6 citations
Original Research
Published on 18 May 2021
Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.672769
- 6,150 views
- 22 citations
Original Research
Published on 07 May 2021
CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.624104
- 20,296 views
- 19 citations
Original Research
Published on 07 May 2021
Effects of a Common Eight Base Pairs Duplication at the Exon 7-Intron 7 Junction on Splicing, Expression, and Function of OCT1
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.661480
- 3,960 views
- 2 citations
Review
Published on 30 Apr 2021
Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.671298
- 7,913 views
- 26 citations
Original Research
Published on 30 Apr 2021
Genetic Variants in Cytosolic Phospholipase A2 Associated With Nonsteroidal Anti-Inflammatory Drug–Induced Acute Urticaria/Angioedema
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.667824
- 4,522 views
- 15 citations
Review
Published on 30 Apr 2021
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.651720
- 32,703 views
- 54 citations
Original Research
Published on 29 Apr 2021
Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson’s Disease
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.640603
- 5,031 views
- 16 citations
Original Research
Published on 29 Apr 2021
Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.660639
- 6,442 views
- 6 citations
Original Research
Published on 28 Apr 2021
The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.634016
- 17,427 views
- 27 citations
Review
Published on 26 Apr 2021
Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.588063
- 30,807 views
- 36 citations
Original Research
Published on 22 Apr 2021
Robust Performance of Potentially Functional SNPs in Machine Learning Models for the Prediction of Atorvastatin-Induced Myalgia
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.605764
- 4,959 views
- 9 citations
Original Research
Published on 22 Apr 2021
CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.653525
- 6,762 views
- 15 citations